Research delivers insight into the Parkinson's Disease - Pipeline Review, H1 2016
Parkinson's Disease - Pipeline Review, H1 2016 is a new market research publication announced by Reportstack. This report provides an overview of the Parkinson's Disease pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Parkinson's Disease, complete with analysis by stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects.
To access full report with TOC, please visit Parkinson's Disease - Pipeline Review, H1 2016
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global therapeutic landscape of Parkinson's Disease
- The report reviews pipeline therapeutics for Parkinson's Disease by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Parkinson's Disease
- The report reviews pipeline therapeutics for Parkinson's Disease by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Parkinson's Disease
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Parkinson's Disease
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Parkinson's Disease
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
Companies Mentioned
arkinson's Disease - Companies Involved in Therapeutics Development AC Immune SA Acelot, Inc. Acorda Therapeutics, Inc. Addex Therapeutics Ltd Advinus Therapeutics Ltd Aeolus Pharmaceuticals, Inc. AFFiRiS AG Alexza Pharmaceuticals, Inc. Amabiotics SAS Amarantus Bioscience Holdings, Inc. American Gene Technologies International Inc. Anavex Life Sciences Corp. Angita B.V. Antoxis Limited APeT Holding BV ApoPharma Inc.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###
posted by Reportstack @ 00:40
0 Comments
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home